Are there differences in risk of pseudoprogression in various immunotherapy combination regimens?
For example are you more likely to see pseudoprogression in patients receiving CTLA4+PDL1 inhibition than PDL1 alone? Can chemoimmunotherapy still have pseudoprogression?
Community PollStarted
For which immunotherapy regimens do you consider pseudo-progression a possibility?
78 physicians have voted
Join Mednetto vote and see how they answered.